◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

国发股份

国发股份
Loading...
Price History
Market Data
Market Cap3.2B
Market Cap (USD)$441.0M
P/E Ratio-
P/B Ratio-
EPS-0.18
Dividend Yield-
D/E Ratio0.23
Current Ratio3.46
Market SegmentMain Board
CurrencyCNY
Business Overview

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning granules under the Guofa brand; ethanol disinfectant; honeysuckle mixture; feier syrup; medicinal wine for traumatic injury under the Hippocampus brand; and sea snake medicinal wine. In addition, the company offers forensic DNA testing equipment, reagents, and consumables; and technical services, including DNA testing services. Further, it engages in culture and arts activities. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.

证监会行业分类 F51批发业 SSE
Key Financial Metrics
340.0M
Revenue
-91.9M
Net Income
-0.18
EPS (Diluted)
-8.1M
Free Cash Flow
Profitability
Gross Margin -
Operating Margin -27.0%
Net Profit Margin -27.0%
EBITDA -91.7M
Returns & Efficiency
Return on Assets (ROA) -9.5%
Return on Equity (ROE) -11.7%
Dividend Yield -
EPS -0.18
Financial Health
Total Assets 967.0M
Total Debt 179.0M
Debt to Equity 0.23x
Current Ratio 3.46
Company Info
IndustryF51批发业
Market SegmentMain Board
CurrencyCNY
Fiscal Year2024
Peers
2.7T
P/E: 7.6
2.5T
P/E: 7.2
2.4T
P/E: 8.7
CNOOC LIMITED
600938
2.0T
P/E: 16.2
1.9T
P/E: 25.6
1.8T
P/E: 20.1
1.8T
P/E: 7.3
1.2T
P/E: 6.9
Stock Chart
Open Full Chart View

Full charting with technical indicators, candlestick, line charts, and more.

Company Profile
General Information
Company Name国发股份
Ticker600538
ExchangeSSE
Sector证监会行业分类
IndustryF51批发业
Market SegmentMain Board
Fiscal Year2024
CurrencyCNY
Financial Summary
Market Cap3.2B
Market Cap (USD)$441.0M
Revenue340.0M
Net Income-91.9M
P/E Ratio-
EPS-0.18
Net Margin-27.0%
ROE-11.7%
Dividend Yield-
Description

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly operated and franchised chain drugstores. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; weichangning granules under the Guofa brand; ethanol disinfectant; honeysuckle mixture; feier syrup; medicinal wine for traumatic injury under the Hippocampus brand; and sea snake medicinal wine. In addition, the company offers forensic DNA testing equipment, reagents, and consumables; and technical services, including DNA testing services. Further, it engages in culture and arts activities. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...